Femoston 2/10 Tablet is a hormone replacement therapy medication containing Estradiol (2mg) and Dydrogesterone (10mg), designed to alleviate symptoms associated with menopause and prevent osteoporosis in postmenopausal women. Estradiol, a form of estrogen, helps restore diminished hormone levels, reducing common menopausal symptoms such as hot flashes, night sweats, vaginal dryness, and mood swings. Dydrogesterone, a synthetic progestogen, complements estradiol by protecting the endometrium from hyperplasia caused by unopposed estrogen therapy, thereby reducing the risk of endometrial cancer. Femoston 2/10 is typically prescribed for women who have not undergone hysterectomy and require combined estrogen-progestogen therapy. The medication is administered orally, usually once daily, and treatment duration depends on individual patient needs and medical advice. It is important to use Femoston 2/10 under medical supervision, as hormone replacement therapy may carry risks such as increased chances of blood clots, stroke, or breast cancer in certain populations. Patients should discuss their medical history and any contraindications with their healthcare provider before starting treatment. Regular follow-up is recommended to monitor therapy effectiveness and manage any adverse effects.